2466 related articles for article (PubMed ID: 9883760)
1. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
[TBL] [Abstract][Full Text] [Related]
4. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
[TBL] [Abstract][Full Text] [Related]
5. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
Sheldon S; Hasleton PS; Yonan NA; Rhaman AN; Deiraniya AK; Campbell CS; Brooks NH; Dyer PA
Transplantation; 1994 Sep; 58(6):719-22. PubMed ID: 7940693
[TBL] [Abstract][Full Text] [Related]
6. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
[TBL] [Abstract][Full Text] [Related]
8. HLA mismatching and outcome in heart, heart-lung, and single lung transplantation.
Keogh A; Kaan A; Doran T; Macdonald P; Bryant D; Spratt P
J Heart Lung Transplant; 1995; 14(3):444-51. PubMed ID: 7654729
[TBL] [Abstract][Full Text] [Related]
9. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
[TBL] [Abstract][Full Text] [Related]
10. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Balan V; Ruppert K; Demetris AJ; Ledneva T; Duquesnoy RJ; Detre KM; Wei YL; Rakela J; Schafer DF; Roberts JP; Everhart JE; Wiesner RH
Hepatology; 2008 Sep; 48(3):878-88. PubMed ID: 18752327
[TBL] [Abstract][Full Text] [Related]
12. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424
[TBL] [Abstract][Full Text] [Related]
14. Rejection episodes.
Koyama H; Cecka JM
Clin Transpl; 1992; ():391-404. PubMed ID: 1306715
[TBL] [Abstract][Full Text] [Related]
15. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
17. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits.
Kobashigawa JA; Stevenson LW; Brownfield ED; Gleeson MP; Moriguchi JD; Kawata N; Minkley R; Drinkwater DC; Laks H
J Heart Lung Transplant; 1995; 14(5):963-7. PubMed ID: 8800734
[TBL] [Abstract][Full Text] [Related]
19. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L
J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]